Alejandro Olivé-Marqués

Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus

Íñigo Rúa‐Figueroa, María Galindo-Izquierdo, Jaime Calvo‐Alén et al. · Seminars in Arthritis and Rheumatism · 2017 · 157 citations · Full text

Life Sciences, Clinical Sciences, Immunology +12

Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

Monica Calderón-Goercke, J. Loricera, Vicente Aldasoro et al. · Seminars in Arthritis and Rheumatism · 2019 · 109 citations · Full text

Life Sciences, Pharmacotherapy, Surgery +6

Cardiovascular Events in Systemic Lupus Erythematosus

Antonio Fernández‐Nebro, Íñigo Rúa‐Figueroa, Francisco Javier López-Longo et al. · Medicine · 2015 · 109 citations · Full text

Medicine, Cardiology, Clinical Sciences +14

Comprehensive Description of Clinical Characteristics of a Large Systemic Lupus Erythematosus Cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) With Emphasis on Complete Versus Incomplete Lupus Differences

Íñigo Rúa‐Figueroa, Patricia Richi, Francisco Javier López-Longo et al. · Medicine · 2015 · 59 citations · Full text

Life Sciences, Clinical Sciences, Immunology +17

Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality

Leyre Riancho‐Zarrabeitia, Víctor Martínez‐Taboada, Íñigo Rúa‐Figueroa et al. · Lupus · 2020 · 52 citations · Full text

Life Sciences, Immunology, Autoimmunity +16